Fidelity Disrupt Medicin ETFFMEDETF

13F holders, Q4 2025 (December 31)
12holders +5
4new positions
0sold out
$27.29avg. 13F price*

At the end of Q4 2025, 12 institutions reported holding Fidelity Disrupt Medicin ETF (FMED) in their 13F filings, up 5 from Q3 2025. 4 opened new positions and 0 sold out. The largest holders were FMR LLC ($19.8M), Wealth Enhancement Advisory Services, LLC ($19.7M) and Jane Street Group, LLC ($2.5M).

Company
Fidelity Disrupt Medicin ETF
CUSIP
316092147
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q1 2024: 8Q1 2024Q2 2024: 8Q2 2024Q3 2024: 7Q3 2024Q4 2024: 8Q4 2024Q1 2025: 6Q1 2025Q2 2025: 7Q2 2025Q3 2025: 7Q3 2025Q4 2025: 12Q4 2025Q1 2026: 11Q1 2026Q2 2026: 11Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions4$736K
Exits0$0

All 13F filers, Q3 2025 → Q4 2025: 103,865 shares bought and 540 shares sold, net +103,325 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 12 holders

FMR LLC 0.00% Add +0.0% 733,000 $19.8M
Wealth Enhancement Advisory Services, LLC 0.03% Add +4.6% 714,991 $19.7M
Jane Street Group, LLC 0.00% Add +95.4% 91,414 $2.5M
BXM Wealth LLC 0.19% New 8,990 $243K
Vise Technologies, Inc. 0.00% New 8,648 $234K
Virtu Financial LLC 0.01% New 8,424 $228K
Glass Jacobson Investment Advisors llc 0.01% Add +44.0% 1,260 $34K
BlackRock, Inc. 0.00% New 1,154 $31K
UBS Group AG 0.00% Reduce -71.0% 221 $6K
Central Pacific Bank - Trust Division 0.00% No change 97 $3K
Glen Eagle Advisors, LLC 0.00% No change 90 $2K
Quattro Advisors LLC 0.00% — 2 $48

"% of holder's portfolio" is FMED's weight in each manager's 13F, not the share of Fidelity Disrupt Medicin ETF the manager owns.